Hide metadata

dc.date.accessioned2013-03-12T12:13:10Z
dc.date.available2013-03-12T12:13:10Z
dc.date.issued2007en_US
dc.date.submitted2007-07-03en_US
dc.identifier.citationRomundstad, Luis. Effects of Glucocorticoids and Nonsteroidal Anti-inflammatory Drugs on Postoperative and Experimental Pain. Doktoravhandling, University of Oslo, 2007en_US
dc.identifier.urihttp://hdl.handle.net/10852/28076
dc.description.abstractOptimizing non-opioid pain relief postoperatively is necessary to spare opioids, reduce opioid related side effects, increase the quality of analgesia, facilitate postoperative recovery and hopefully prevent chronic postoperative pain. In the present thesis, Luis Romundstad and co-workers investigated the effect of adding paracetamol (propacetamol 2 g i.v.) to an NSAID (ketorolac 30 mg i.v.) on human experimental pain, and the effect of a glucocorticoid (methylprednisolone 125 mg i.v.) on hyperalgesia, rescue analgesic use, postoperative emesis and fatigue in human postoperative and experimental pain models. They compared methylprednisolone with placebo, an NSAID (ketorolac 30 mg and 60 mg i.v.), or a selective COX-2 inhibitor (parecoxib 40 mg i.v.). They also studied the prevalence of chronic postoperative pain and sensory changes and the effect of methylprednisolone and parecoxib on these variables. <br> For the first time a glucocorticoid (methylprednisolone), and an NSAID (ketorolac), was shown to decrease secondary hyperalgesia, indicating a central anti-hyperalgesic effect of these drugs. Methylprednisolone and ketorolac increased the tolerance threshold for painful pressure, and adding paracetamol to ketorolac increased this tolerance further compared with ketorolac alone. Methylprednisolone and the active comparators ketorolac and parecoxib reduced acute postoperative pain. Methylprednisolone also reduced postoperative emesis, fatigue and persistent postoperative hyperesthesia. This thesis adds to the pool of evidence documenting that chronic postoperative pain and sensory changes are relatively common, with a 13% prevalence of pain and 46% hyperesthesia one year after breast augmentation surgery. According to the results in the present thesis we advocate the combination of NSAIDs and paracetamol, and/or a single, appropriate perioperative dose of a glucocorticoid in order to optimize postoperative pain relief.nor
dc.language.isonoben_US
dc.relation.haspartI Romundstad L, Stubhaug A, Niemi G, Rosseland LA, Breivik H. Adding propacetamol to ketorolac increases the tolerance to painful pressure. Eur J Pain 2006;10:177-83. The paper is not available in DUO. The published version is available at: http://dx.doi.org/10.1016/j.ejpain.2005.03.003
dc.relation.haspartII Stubhaug A, Romundstad L, Torill Kaasa, Breivik H. Methylprednisolone and ketorolac rapidly reduce hyperalgesia around a skin burn injury and increase pressure pain thresholds. Acta Anaesthesiol Scand. 2007 Oct;51(9):1138-46. The paper is not available in DUO. The published version is available at: http://dx.doi.org/10.1111/j.1399-6576.2007.01415.x
dc.relation.haspartIII Romundstad L, Breivik H, Niemi G, Helle A, Stubhaug A. Methylprednisolone intravenously 1 day after surgery has sustained analgesic and opioid-sparing effects. Acta Anaesthesiol Scand. 2004;48:1223-31. The paper is not available in DUO. The published version is available at: http://dx.doi.org/10.1111/j.1399-6576.2004.00480.x
dc.relation.haspartIV Romundstad L, Stubhaug A, Roald H, Skolleborg K, Haugen T, Narum J, Breivik H. Methylprednisolone reduces pain, emesis, and fatigue after breast augmentation surgery: a single-dose, randomized, parallel-group study with methylprednisolone 125 mg, parecoxib 40 mg, and placebo. Anesth Analg. 2006;102:418-25. The paper is not available in DUO. The published version is available at: http://dx.doi.org/10.1213/01.ane.0000194358.46119.e1
dc.relation.haspartV Romundstad L, Stubhaug A, Skolleborg K, Roald H, Romundstad P, Breivik H. Chronic pain and sensory changes after augmentation-mammoplasty: Long term effects of preincisional administration of methylprednisolone. Pain. 2006;124:92-9. The paper is not available in DUO. The published version is available at: http://dx.doi.org/10.1016/j.pain.2006.03.020
dc.relation.urihttp://dx.doi.org/10.1016/j.ejpain.2005.03.003
dc.relation.urihttp://dx.doi.org/10.1111/j.1399-6576.2007.01415.x
dc.relation.urihttp://dx.doi.org/10.1111/j.1399-6576.2004.00480.x
dc.relation.urihttp://dx.doi.org/10.1213/01.ane.0000194358.46119.e1
dc.relation.urihttp://dx.doi.org/10.1016/j.pain.2006.03.020
dc.titleEffects of Glucocorticoids and Nonsteroidal Anti-inflammatory Drugs on Postoperative and Experimental Painen_US
dc.typeDoctoral thesisen_US
dc.date.updated2008-02-01en_US
dc.creator.authorRomundstad, Luisen_US
dc.subject.nsiVDP::700en_US
cristin.unitcode130000en_US
cristin.unitnameMedisinske fakulteten_US
dc.identifier.bibliographiccitationinfo:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:dissertation&rft.au=Romundstad, Luis&rft.title=Effects of Glucocorticoids and Nonsteroidal Anti-inflammatory Drugs on Postoperative and Experimental Pain&rft.inst=University of Oslo&rft.date=2007&rft.degree=Doktoravhandlingen_US
dc.identifier.urnURN:NBN:no-15985en_US
dc.type.documentDoktoravhandlingen_US
dc.identifier.duo63309en_US
dc.contributor.supervisorAudun Stubhaugen_US
dc.identifier.bibsys07132108xen_US
dc.identifier.fulltextFulltext https://www.duo.uio.no/bitstream/handle/10852/28076/1/DUO_532_Romundstad.pdf


Files in this item

Appears in the following Collection

Hide metadata